KRAS mutations occur most frequently in 30–40% of all colorectal cancers [11] and BRAF mutations are present at a frequency of 5–22%, in which the constitutively activated BRAFV600E variant accounts for ∼90% of all the BRAF mutations [12]. This evidence concerns the gene BRAF and colorectal cancer.